Esperion Therapeutics, Inc. (NASDAQ:ESPR) Q1 2025 Earnings Call Transcript May 6, 2025
Esperion Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.21 EPS, expectations were $-0.18.
Operator: Ladies and gentlemen, thank you for standing by, and welcome. At this time, all participants are in a listen-only mode. Following the presentation, there will be a question-and-answer session. Please be advised that today’s conference call will be recorded. I would now like to hand...
